| Rite Aid Pharmacy 01970 | |
| 431 Haledon Ave, Haledon, New Jersey 07508 | |
| (973) 904-0550 |
| Name | Rite Aid Pharmacy 01970 |
|---|---|
| Organization Name | Rite Aid Of New Jersey Inc |
| Location | 431 Haledon Ave, Haledon, New Jersey 07508 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (973) 904-0550 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Virginia Commonwealth University has experts available in pediatric obesity, psychology, medicine and fashion to discuss a variety of topics including healthy eating, physical activity, lifestyle programs and strategies, trends and causes related to childhood obesity during the month of September.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind experts' recommendations.
Scientists have decoded the DNA of the parasitic worm that causes trichinosis, a disease linked to eating raw or undercooked pork or carnivorous wild game animals, such as bear and walrus.
› Verified 4 days ago
| NPI Number | 1043737190 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 431 Haledon Ave, Haledon, NJ 07508 |
| Phone Number | 973-904-0550 |
News Archive
Virginia Commonwealth University has experts available in pediatric obesity, psychology, medicine and fashion to discuss a variety of topics including healthy eating, physical activity, lifestyle programs and strategies, trends and causes related to childhood obesity during the month of September.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind experts' recommendations.
Scientists have decoded the DNA of the parasitic worm that causes trichinosis, a disease linked to eating raw or undercooked pork or carnivorous wild game animals, such as bear and walrus.
› Verified 4 days ago
| NPI Number | 1225553019 |
| Organization Name | WALGREEN CO |
| Doing Business As | RITE AID #20407 |
| Type | Pharmacy |
| Address | 431 Haledon Ave, Haledon, NJ 07508 |
| Phone Number | 973-904-0550 |
News Archive
Virginia Commonwealth University has experts available in pediatric obesity, psychology, medicine and fashion to discuss a variety of topics including healthy eating, physical activity, lifestyle programs and strategies, trends and causes related to childhood obesity during the month of September.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind experts' recommendations.
Scientists have decoded the DNA of the parasitic worm that causes trichinosis, a disease linked to eating raw or undercooked pork or carnivorous wild game animals, such as bear and walrus.
› Verified 4 days ago
| NPI Number | 1992814354 |
| Organization Name | RITE AID OF NEW JERSEY INC |
| Doing Business As | RITE AID PHARMACY 01970 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 431 Haledon Avenue, Haledon, NJ 07508 |
| Phone Number | 973-904-0550 |
News Archive
Virginia Commonwealth University has experts available in pediatric obesity, psychology, medicine and fashion to discuss a variety of topics including healthy eating, physical activity, lifestyle programs and strategies, trends and causes related to childhood obesity during the month of September.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind experts' recommendations.
Scientists have decoded the DNA of the parasitic worm that causes trichinosis, a disease linked to eating raw or undercooked pork or carnivorous wild game animals, such as bear and walrus.
› Verified 4 days ago
News Archive
Virginia Commonwealth University has experts available in pediatric obesity, psychology, medicine and fashion to discuss a variety of topics including healthy eating, physical activity, lifestyle programs and strategies, trends and causes related to childhood obesity during the month of September.
Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials (Study 104) evaluating a single tablet regimen containing tenofovir alafenamide (TAF) for the treatment of HIV-1 infection in treatment-naïve adults.
Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a non-binding Letter of Intent with the National Institute on Drug Abuse (NIDA) to conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. It is anticipated that NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the trial and that Catalyst will contribute approximately $2.5 million in resources as part of the estimated $10 million trial cost.
The COVID-19 pandemic knocked many women off schedule for important health appointments, a new study finds, and many didn't get back on schedule even after clinics reopened. The effect may have been greatest in areas where such care is already likely falling behind experts' recommendations.
Scientists have decoded the DNA of the parasitic worm that causes trichinosis, a disease linked to eating raw or undercooked pork or carnivorous wild game animals, such as bear and walrus.
› Verified 4 days ago
Family Drug Shops Haledon Type: Pharmacy Location: 183 Belmont Avenue, Haledon, New Jersey 07508 Phone: (973) 917-3175 | |
Rite Aid Pharmacy 01970 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 431 Haledon Ave, Haledon, New Jersey 07508 Phone: (973) 904-0550 | |
Walgreens #13083 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 447 Belmont Ave, Haledon, New Jersey 07508 Phone: (973) 389-2370 |